This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pseudomyxoma peritonei

Authoring team

This accompanies 3-5% of mucinous ovarian tumours, and consists of gelatinous masses of mucin and tumour scattered through the peritoneal and abdominal cavities as a result of of rupture of a mucinous cystadenoma. It may compromise vital structures by local spread, and rarely, may cause death.

The condition may also arise after rupture of a mucocoele of the appendix which commonly coexists with the ovarian mucocoele. It is postulated that ovarian tumours may represent secondary metastasis from a gastrointestinal tumour (1). This is supported by evidence that most women with this condition do not have an overt rupture of an ovarian tumour. Also 90% have concurrent appendicular or intestinal tumours (1).

This condition is treated via surgical debulking.

This condition has a 30-50% 10 year survival.

Reference:

  • 1) Fox H (1996). Br J Obs Gynae, 103, 197

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.